Ikarian Capital, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37,576
-99.3%
11
-100.0%
0.01%
-99.4%
Q2 2023$5,216,212
-9.2%
135,486
-15.6%
0.83%
-36.2%
Q1 2023$5,743,793
-9.2%
160,4860.0%1.30%
-14.7%
Q4 2022$6,327,963
+9.2%
160,4860.0%1.53%
+32.2%
Q3 2022$5,794,000
-20.4%
160,486
-33.0%
1.16%
-13.0%
Q2 2022$7,283,000
-0.5%
239,4410.0%1.33%
+37.9%
Q1 2022$7,320,000
+30.8%
239,441
+33.7%
0.96%
+15.5%
Q4 2021$5,597,000
-68.3%
179,138
-84.5%
0.83%
-32.9%
Q3 2021$17,635,000
+15.5%
1,154,138
+40.8%
1.24%
+0.6%
Q2 2021$15,262,000
+7.8%
819,706
+3.7%
1.23%
+159.2%
Q1 2021$14,154,000
+312.4%
790,676
+254.3%
0.48%
+215.2%
Q4 2020$3,432,000
+38.9%
223,1730.0%0.15%
-15.6%
Q3 2020$2,470,000
-33.9%
223,173
-25.2%
0.18%
-39.9%
Q2 2020$3,739,000
-25.7%
298,173
-32.8%
0.30%
-21.2%
Q1 2020$5,030,000
+57.6%
443,582
+82.2%
0.38%
-26.9%
Q4 2019$3,192,000243,4700.52%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$10,277,99912.45%
COMMODORE CAPITAL LP 1,845,000$71,032,5007.98%
Altium Capital Management LP 228,000$8,778,0006.64%
TLS Advisors LLC 33,756$1,3005.58%
GREAT POINT PARTNERS LLC 530,000$20,405,0003.99%
DAFNA Capital Management LLC 280,538$10,800,7132.95%
Paradigm Biocapital Advisors LP 989,327$38,089,0902.94%
Nan Fung Group Holdings Ltd 114,380$4,403,6302.81%
Avoro Capital Advisors LLC 4,900,000$188,650,0002.56%
Ghost Tree Capital, LLC 185,000$7,122,5002.35%
View complete list of XENON PHARMACEUTICALS INC shareholders